AGREEMENT AND PLAN OF MERGER DATED AS OF FEBRUARY 24, 2021 AMONG MERCK SHARP & DOHME CORP., PANAMA MERGER SUB, INC. AND PANDION THERAPEUTICS, INC.Agreement and Plan of Merger • February 25th, 2021 • Pandion Therapeutics, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, the respective boards of directors of the Company, Parent and Merger Sub have approved the acquisition of the Company by Parent on the terms and subject to the conditions set forth in this Agreement;
TENDER AND SUPPORT AGREEMENTTender and Support Agreement • February 25th, 2021 • Pandion Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of February 24, 2021, is entered into by and among [•] (“Stockholder”), Merck Sharp & Dohme Corp., a New Jersey corporation (“Parent”) and Panama Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).
